Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel/Gemcitabine/Trastuzumab
Sponsor: Jungsil Ro